Bupropion Stereoselective Disposition and CYP2D6-mediated Drug Interactions in Healthy Volunteers

Clinical trial NCT03420469 · COMPLETED

Trial details

NCT number: NCT03420469
Sponsor: Indiana University
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Adverse Effect of Drug Therapy Metabolism Medications (Diagnosis)

Start date: 2018-06-05
Primary completion: 2019-05-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.